A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Clinical trial NCT07215312 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07215312
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-13
- Primary completion
- 2026-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.